Literature DB >> 3039372

New human and simian HIV-related retroviruses possess functional transactivator (tat) gene.

S K Arya, B Beaver, L Jagodzinski, B Ensoli, P J Kanki, J Albert, E M Fenyo, G Biberfeld, J F Zagury, F Laure.   

Abstract

New human retroviruses antigenically related to HIV and even more closely to STLV-III have been recently isolated from individuals from some West African countries. One of these viruses, HTLV-IVP, was reportedly isolated from lymphocytes of a healthy female prostitute. Another isolate, LAV-2FG, was obtained from an AIDS patient and third, SBL-6669, from an individual with lymphadenopathy. Current epidemiological studies indicate that some of these virus isolates cause immune deficiency whereas others may not or may be less efficient at inducing immune deficiency. Similarly, STLV-III apparently does not cause immune deficiency in its natural host, African green monkey. A novel feature of HIV is the possession of a gene termed tat, which is implicated in its pathobiology. We report here that, like HIV, HTLV-IVP, LAV-2FG (HIV-2) and SBL-6669, as well as STLV-IIIAGM possess the putative tat gene, irrespective of their pathogenic potential in vivo. Interestingly, HTLV-IVP/LAV-2FG long terminal repeat (LTR) is equally well transactivated by the HTLV-IVP/LAV-2FG and HTLV-IIIB tat function, HTLV-IIIB LTR responds better to its own tat function.

Entities:  

Mesh:

Year:  1987        PMID: 3039372     DOI: 10.1038/328548a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  34 in total

Review 1.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

2.  Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines.

Authors:  M G Anderson; J E Clements
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs.

Authors:  S Schwartz; B K Felber; G N Pavlakis
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

4.  Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.

Authors:  M J Orsini; C M Debouck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein.

Authors:  J Hauber; M H Malim; B R Cullen
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein.

Authors:  B K Felber; C M Drysdale; G N Pavlakis
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.

Authors:  L Sherman; A Yaniv; H Lichtman-Pleban; S R Tronick; A Gazit
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.

Authors:  J F Zagury; G Franchini; M Reitz; E Collalti; B Starcich; L Hall; K Fargnoli; L Jagodzinski; H G Guo; F Laure
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Functional analysis of the Tat trans activator of human immunodeficiency virus type 2.

Authors:  R Fenrick; M H Malim; J Hauber; S Y Le; J Maizel; B R Cullen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Inhibition of HIV-1 expression by HIV-2.

Authors:  J Rappaport; S K Arya; M W Richardson; G Baier-Bitterlich; P E Klotman
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.